Dopamine receptor agonists differ in their actions on cardiac ion channels

Author： Hurst R.S.   Higdon N.R.   Lawson J.A.   Clark M.A.   Rutherford-Root K.L.   McDonald W.G.   Haas J.V.   McGrath J.P.   Meglasson M.D.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.482, Iss.1, 2003-12, pp. : 31-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The nicotinic receptor agonists (-)-nicotine and isoarecolone differ in their effects on dopamine release in the nucleus accumbens

By Mirza N.R.   Qi P.   Stolerman I.P.   Zetterstrom T.S.C.  

European Journal of Pharmacology, Vol. 295, Iss. 2, 1996-01 ,pp. : 207-210

Elsevier

Access to resources Recommend Favorite

Dopamine receptor agonists for treating prolactinomas

By Colao Annamaria   Somma Carolina di   Lombardi Gaetano   Pivonello Rosario   Sarno Antonella di  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 6, 2002-06 ,pp. : 787-800

Informa Healthcare

Access to resources Recommend Favorite

Dopamine receptor agonists linked with impulse control disorders

By  

Reactions Weekly, Vol. 1, Iss. 1117, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Dopamine D1 receptor agonists as antiparkinson drugs

By Mailman R.B.   Nichols D.E.  

Trends in Pharmacological Sciences, Vol. 19, Iss. 7, 1998-07 ,pp. : 255-256

Elsevier

Access to resources Recommend Favorite

Dopamine Receptor Agonists for Protection and Repair in Parkinson's Disease

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 12, 2008-08 ,pp. : 1089-1099

Bentham Science Publishers

Access to resources Recommend Favorite